Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Avon, IN
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Avon, IN
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Evansville, IN
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Evansville, IN
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Council Bluffs, IA
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Council Bluffs, IA
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Bangor, ME
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Bangor, ME
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Fall River, MA
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Fall River, MA
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Troy, MI
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Troy, MI
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Saint Peters, MO
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Saint Peters, MO
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Las Vegas, NV
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Nashua, NH
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Nashua, NH
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Berlin, NJ
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Berlin, NJ
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Elizabeth, NJ
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Elizabeth, NJ
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Albany, NY
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Albany, NY
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Charlotte, NC
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Salisbury, NC
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Salisbury, NC
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Akron, OH
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Akron, OH
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Reading, PA
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Reading, PA
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Moncks Corner, SC
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Moncks Corner, SC
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Orangeburg, SC
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Memphis, TN
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Memphis, TN
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Edinburg, TX
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Edinburg, TX
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Fort Worth, TX
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Houston, TX
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Midland, TX
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Midland, TX
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
New Braunfels, TX
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
New Braunfels, TX
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
North Richland Hills, TX
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
North Richland Hills, TX
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
San Antonio, TX
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Sugar Land, TX
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Virginia Beach, VA
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Spokane, WA
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Spokane, WA
Click here to add this to my saved trials
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Surrey,
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Surrey,
Click here to add this to my saved trials
Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic Patients
Clinical Protocol to Investigate the Efficacy of Amlexanox vs. Placebo for Treatment of Glucose and Lipid Abnormalities in Obese Type 2 Diabetics
Status: Enrolling
Updated:  12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic Patients
Clinical Protocol to Investigate the Efficacy of Amlexanox vs. Placebo for Treatment of Glucose and Lipid Abnormalities in Obese Type 2 Diabetics
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Inflammation Inhibition in Prediabetic Humans
Inflammation Inhibition for Microvascular and Autonomic Dysfunction in Obese Prediabetic Humans
Status: Enrolling
Updated:  12/31/1969
University of Iowa
mi
from
Iowa City, IA
Inflammation Inhibition in Prediabetic Humans
Inflammation Inhibition for Microvascular and Autonomic Dysfunction in Obese Prediabetic Humans
Status: Enrolling
Updated: 12/31/1969
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated:  12/31/1969
UI Health Care-River Crossing
mi
from
Riverside, IA
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated: 12/31/1969
UI Health Care-River Crossing
mi
from
Riverside, IA
Click here to add this to my saved trials
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated:  12/31/1969
Akron Mercy Medical Clinic
mi
from
Akron, IA
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated: 12/31/1969
Akron Mercy Medical Clinic
mi
from
Akron, IA
Click here to add this to my saved trials
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated:  12/31/1969
Iowa Specialty Hospitals - Belmond Clinic
mi
from
Belmond, IA
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated: 12/31/1969
Iowa Specialty Hospitals - Belmond Clinic
mi
from
Belmond, IA
Click here to add this to my saved trials
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated:  12/31/1969
Employee Health Clinic, Mercy Cedar Rapids
mi
from
Cedar Rapids, IA
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated: 12/31/1969
Employee Health Clinic, Mercy Cedar Rapids
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated:  12/31/1969
Iowa Speciality Hospitals - Clarion Clinic
mi
from
Clarion, IA
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated: 12/31/1969
Iowa Speciality Hospitals - Clarion Clinic
mi
from
Clarion, IA
Click here to add this to my saved trials
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated:  12/31/1969
Great River Medical Group
mi
from
Davenport, IA
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated: 12/31/1969
Great River Medical Group
mi
from
Davenport, IA
Click here to add this to my saved trials
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated:  12/31/1969
Des Moines University Family Medicine Clinic
mi
from
Des Moines, IA
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated: 12/31/1969
Des Moines University Family Medicine Clinic
mi
from
Des Moines, IA
Click here to add this to my saved trials
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated:  12/31/1969
Grinnell Regional Family Practice
mi
from
Grinnell, IA
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated: 12/31/1969
Grinnell Regional Family Practice
mi
from
Grinnell, IA
Click here to add this to my saved trials
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated:  12/31/1969
Knoxville Hospital Clinic
mi
from
Knoxville, IA
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated: 12/31/1969
Knoxville Hospital Clinic
mi
from
Knoxville, IA
Click here to add this to my saved trials
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated:  12/31/1969
Newton Clinic, P.C.
mi
from
Newton, IA
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated: 12/31/1969
Newton Clinic, P.C.
mi
from
Newton, IA
Click here to add this to my saved trials
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated:  12/31/1969
Siouxland Community Health Center
mi
from
Sioux City, IA
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated: 12/31/1969
Siouxland Community Health Center
mi
from
Sioux City, IA
Click here to add this to my saved trials
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated:  12/31/1969
Burlington Area Family Practice Center
mi
from
West Burlington, IA
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care
Status: Enrolling
Updated: 12/31/1969
Burlington Area Family Practice Center
mi
from
West Burlington, IA
Click here to add this to my saved trials
A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus
A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Canagliflozin on Renal Endpoints in Adult Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Little Rock, AR
A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus
A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Canagliflozin on Renal Endpoints in Adult Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus
A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Canagliflozin on Renal Endpoints in Adult Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Carmichael, CA
A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus
A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Canagliflozin on Renal Endpoints in Adult Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Carmichael, CA
Click here to add this to my saved trials
A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus
A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Canagliflozin on Renal Endpoints in Adult Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Concord, CA
A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus
A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Canagliflozin on Renal Endpoints in Adult Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Concord, CA
Click here to add this to my saved trials
A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus
A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Canagliflozin on Renal Endpoints in Adult Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Pismo Beach, CA
A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus
A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Canagliflozin on Renal Endpoints in Adult Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Pismo Beach, CA
Click here to add this to my saved trials
A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus
A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Canagliflozin on Renal Endpoints in Adult Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Roseville, CA
A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus
A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Canagliflozin on Renal Endpoints in Adult Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Roseville, CA
Click here to add this to my saved trials
A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus
A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Canagliflozin on Renal Endpoints in Adult Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Thousand Oaks, CA
A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus
A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Canagliflozin on Renal Endpoints in Adult Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Thousand Oaks, CA
Click here to add this to my saved trials